[1
]
From the University of California, San Francisco (S.L.H.), and Genentech, South San
Francisco (D.M., P.C., H.G.) - both in California; McGill University (A.B.-O., D.L.A.)
and NeuroRx Research (D.L.A.), Montreal, and University of British Columbia, Vancouver,
BC (A.T.) - both in Canada; University Vita-Salute San Raffaele, Milan (G.C.); Barts
and the London School of Medicine and Dentistry, London (G.G.); Medical Faculty, Heinrich
Heine University Düsseldorf, Düsseldorf (H.-P.H.), and the Technical University of
Munich and Munich Cluster for Systems Neurology, Munich (B.H.) - both in Germany;
Icahn School of Medicine at Mount Sinai, New York (F.L.); Hospital Vall d'Hebron University,
Barcelona (X.M.); University of Miami, Miami (K.W.R.); Medical University of Lodz
and Center for Neurology, Lodz, Poland (K.S.); McGovern Medical School, University
of Texas Health Science Center at Houston, Houston (J.S.W.); and F. Hoffmann-La Roche
(G.K., P.F., S.B., N.M.) and University Hospital Basel, University of Basel (L.K.),
Basel, Switzerland.